Sudafed PE Phenylephrine Night

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Chlorphenamine maleate 2mg (From Compap CPM-0117); Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117); Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg;  ;  

Disponible depuis:

JNTL Consumer Health (New Zealand) Limited

DCI (Dénomination commune internationale):

Chlorphenamine maleate 2 mg (From Compap CPM-0117)

forme pharmaceutique:

Film coated tablet

Composition:

Active: Chlorphenamine maleate 2mg (From Compap CPM-0117) Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117) Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg     Excipient: Colloidal silicon dioxide Crospovidone Balance of Compap L-0093 (as Pregelatinised starch, Stearic acid, Povidone and Crospovidone) hydrous Balance of Compap CPM-0117 (as Pregelatinised starch, Stearic acid and Povidone) hydrous Microcrystalline cellulose Opadry orange 85F63129 Pregelatinised maize starch Stearic acid

Type d'ordonnance:

Pharmacy only

Fabriqué par:

Kongo Chemical Co., Ltd

indications thérapeutiques:

For the temporary relief of sinus headache, pain, congestion, and allergic symptoms such as sneezing, blocked or runny nose, itching and watery eyes.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, PVD/PVDC and Al foil - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC and Al foil - 48 tablets - 36 months from date of manufacture stored at or below 30°C

Date de l'autorisation:

2013-12-16